Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1174-1178

  Yue, Chun Mei ^a   Deng, Da Jun ^b   Bi, Mei Xia ^a   Guo, Li Ping ^a   Lu, Shih Hsin ^a  

^a CANCER HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA SEQUENCE; DOWN REGULATION; ESOPHAGUS CANCER RELATED GENE 4; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; MOLECULAR DYNAMICS; POLYMERASE CHAIN REACTION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

EID: 0037714882     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1174     Document Type: Article

References (30)

1. Lu SH. Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China. Mutat Res 2000; 462: 343-353
2. Lu SH, Hsieh LL, Luo FC, Weinstein IB. Amplification of the EGF receptor and c-myc genes in human esophageal cancer. Int J Cancer 1988; 42: 502-505
3. Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, Sugano S, Nakamura Y, Inazawa J. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 2000; 60: 4735-4739
4. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999; 59: 1966-1972
5. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM. Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 2002; 21: 5024-5030
6. Su T, Liu HL, Lu SX, Zhao XJ, Zhou CX, Jin SQ. Cloning and identification of cDNA fragment related to human esophageal cancer. Chinese J Oncology 1998; 20: 254-257
7. Bi MX, Han WD, Lu SX. Using lab on-line to clone and identify the esophageal cancer related gene 4. Acta Biochimicaet Biophysica Sinica 2001; 33: 257-261
8. Jones PA. DNA methylation and cancer. Oncogene 2002; 21: 5358-5360
9. Esteller M. CpG island hypermethylation and tumor suppressor genes: A booming present, a bright future. Oncogene 2002; 21: 5427-5440
10. INK4b and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999; 5: 2704-2713
11. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res 1997; 57: 2619-2622
12. Si HX, Tsao SW, Lam KY, Srivastava G, Liu Y, Wong YC, Shen ZY. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 2001; 173: 71-78
13. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 1998; 58: 3429-3434
14. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid Res 1976; 3: 2303-2308
15. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826
16. Deng DJ, Deng GR, Smith MF, Zhou J, Xin HJ, Powell SM, Lu YY. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography. Nucleic Acid Res 2002; 30: e13
17. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeeste TR, Skinner KA, Laird PW. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001; 61: 3410-3418
18. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: A high-throughout assay to measure DNA methylation. Nucleic Acid Res 2000; 28: e32
19. Tokugawa T, Sugihara H, Tani T, Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002; 62: 4938-4944
20. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Yuraoka K, Ito R, Yasui W. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001; 93: 805-809
21. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60: 5954-5958
22. Widschwendter M, Jones PA. DNA methylation and breast carcinogenesis. Oncogene 2002; 21: 5462-5482
23. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001; 7: 584-589
24. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su HH, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat Genet 2000; 24: 132-138
25. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163-167
26. Beck S, Olek A, Walter J. From genomics to epigenomics: A loftier view of life. Nat Biotechnol 1999; 17: 1144
27. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis: A powerful new tool for lung cancer diagnosis. Oncogene 2002; 21: 5450-5461
28. Nie Y, Liao J, Zhao X, Song Y, Yang GY, Wang LD, Yang CS. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002; 23: 1713-1720
29. Shibata Y, Haruki N, Kuwabar Y, Ishiguro H, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Nishiwaki T, Kudo J, Terashita Y, Konishi S, Sugiura H, Fujii Y. Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 2002; 23: 1695-1699
30. Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, Wang LD, Yang CS. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001; 22: 1615-1623